@article{TGH5580,
author = {Marta Trevisan and Giulia Masi and Giorgio Palù},
title = {Genome editing technologies to treat rare liver diseases},
journal = {Translational Gastroenterology and Hepatology},
volume = {5},
number = {0},
year = {2019},
keywords = {},
abstract = {Liver has a central role in protein and lipid metabolism, and diseases involving hepatocytes have often repercussions on multiple organs and systems. Hepatic disorders are frequently characterized by production of defective or non-functional proteins, and traditional gene therapy approaches have been attempted for years to restore adequate protein levels through delivery of transgenes. Recently, many different genome editing platforms have been developed aimed at correcting at DNA level the defects underlying the diseases. In this Review we discuss the latest applications of these tools applied to develop therapeutic strategies for rare liver disorders, in particular updating the literature with the most recent strategies relying on base editors technology.},
issn = {2415-1289}, url = {https://tgh.amegroups.org/article/view/5580}
}